Why is SPARC falling/rising?

As of 23-Sep, Sun Pharma Advanced Research Company Ltd is experiencing a decline in its stock price, currently at 139.35, which reflects a decrease of 1.7 or 1.21%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 3.63% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The company has also reported a negative book value and weak long-term fundamentals, with net sales declining at an annual rate of 23.40% over the last five years. Furthermore, the stock's liquidity appears to be decreasing, as evidenced by a 12.93% drop in delivery volume compared to the 5-day average.
In the broader market context, the stock's performance has significantly lagged behind the benchmark, with a 1-week return of -3.56% compared to the Sensex's -0.34%. Over the past year, SPARC has generated a return of -36.08%, while the benchmark has only declined by 3.33%. This consistent underperformance against the benchmark over the last three years highlights the stock's ongoing struggles. The company's weak ability to service its debt, as indicated by a poor EBIT to interest ratio, coupled with negative EBITDA, further contributes to the stock's downward trajectory. Overall, these factors suggest a challenging environment for SPARC, leading to its current price decline.